Pharmaceutical

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

European revenues increased 20% compared to same period last yearGross margin of 39% compared to 35% in same period last…

1 year ago

Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market

CHICAGO, IL / ACCESSWIRE / August 8, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

1 year ago

Claigan Webinar – Canadian PFAS Reporting New – Section 71 Reporting of PFAS in Canada

OTTAWA, ON, Aug. 8, 2024 /PRNewswire/ - On August 14, Claigan Environmental Inc. (www.claigan.com) will be presenting a webinar on…

1 year ago

Label-Free Detection Market worth $747 million by 2029 driven by Technological Advancements | MarketsandMarkets™

CHICAGO, Aug. 8, 2024 /PRNewswire/ -- The global Label-Free Detection Market is expected to grow from USD 515 million in 2024…

1 year ago

Sure Med Compliance Partners With Corganics to Improve Education and Access to Clinical CBD Products in Pain Management Settings

MOBILE, Ala., Aug. 8, 2024 /PRNewswire/ -- Sure Med Compliance, a digital healthcare company dedicated to improving outcomes for patients,…

1 year ago

NanoViricides Provides an Update on Its Clinical Program and Strategy – NV-387 Could be As Revolutionary as Antibiotics

SHELTON, CT / ACCESSWIRE / August 8, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader…

1 year ago

Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing

The potential addressable market opportunity for ONP-002 includes an estimated 69 million concussions globallySARASOTA, Fla., Aug. 08, 2024 (GLOBE NEWSWIRE)…

1 year ago

Evoke Pharma, Inc. Supports Gastroparesis Awareness Month

Collaborating with advocacy groups to amplify gastroparesis awareness for millions of patients worldwide Call for action to improve health and…

1 year ago

Harvard Bioscience Announces Second Quarter 2024 Financial Results

HOLLISTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for…

1 year ago

Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results

Quoin Broadens Product Portfolio through Research Agreement with University College Cork, Ireland Company Expands On-going Clinical Trials in Netherton Syndrome…

1 year ago